Atypical Teratoid/Rhabdoid Tumor — Trials

Atypical Teratoid/Rhabdoid Tumor — Trials · CancerIndex

Clinical trials

Registered studies

42 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 15
Recruiting: 6
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Seattle Children's Hospital
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (6)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06465199	Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas	recruiting	Phase 1 / Phase 2	265	Milton S. Hershey Medical CenterOTHER	1	Sep 3, 2026	clinicaltrials
NCT02114229	Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors(SJATRT)	active not recruiting	Phase 2	125	St. Jude Children's Research HospitalOTHER	1	Sep 1, 2026	clinicaltrials